Author(s):
Sanjay Nagdev, Omprakash Agrawal, Md. Rageeb Md. Usman
Email(s):
snsanjurocks@gmail.com
DOI:
10.52711/0974-360X.2023.00548 
Address:
Sanjay Nagdev1*, Omprakash Agrawal2, Md. Rageeb Md. Usman3
1Ph.d Scholar, School of Pharmacy, Madhyanchal Professional University, Ratibad, Bhopal (M.P)
2Professor, School of Pharmacy, Madhyanchal Professional University, Ratibad, Bhopal, (M.P)
3Associate Professor, Smt. S.S. Patil College of Pharmacy, Chopda (Maharashtra)
*Corresponding Author
Published In:
Volume - 16,
Issue - 7,
Year - 2023
ABSTRACT:
Delivery of drugs into the systemic circulation via transdermal drug delivery system is well known. Transdermal drug delivery system is one of the most reliable and convenient delivery system for the delivery across skin. The aim of this research project is to develop a matrix diffusion control transdermal therapeutic system that combines the drug Ramosetron hydrochloride with an amount of hydrophilic and hydrophobic polymers using a solvent extraction method. Ramosetron hydrochloride is a highly potent drug and has an extended duration of action ad minor side effects despite the severity that it undergoes hepatic pass metabolism and therefore the purpose of this study was to prepare a transdermal patch for Ramosetron hydrochloride for the treatment of chemotherapy induced nausea and vomiting (Anti-emetic action) and evaluate it for various parameters.
Cite this article:
Sanjay Nagdev, Omprakash Agrawal, Md. Rageeb Md. Usman. Design and Development of Matrix Diffusion Control Transdermal Drug Delivery System for Antiemetic Drug. Research Journal of Pharmacy and Technology 2023; 16(7):3321-5. doi: 10.52711/0974-360X.2023.00548
Cite(Electronic):
Sanjay Nagdev, Omprakash Agrawal, Md. Rageeb Md. Usman. Design and Development of Matrix Diffusion Control Transdermal Drug Delivery System for Antiemetic Drug. Research Journal of Pharmacy and Technology 2023; 16(7):3321-5. doi: 10.52711/0974-360X.2023.00548 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-7-45
REFERENCES:
1. Banerjee S, Chattopadhyay P, Ghosh A, Datta P and Veer V. Aspect of adhesives in transdermal drug delivery systems. International journal of Adhesion and Adhesives. 2014; 50:70-84. https://doi.org/10.1016/j.ijadhadh.2014.01.001
2. Solanki S, Patel K, Patel J, Patel M, Patel J. Transdermal Drug Delivery Systems: A Review. Research Journal of Pharmacy and Technology.2012; 5(6): 757-763.
3. Chien Y. Development of transdermal drug delivery systems. Drug development and industrial pharmacy. 1987; 13(4): 589-651. https://doi.org/10.3109/03639048709105212
4. Misra A. Transdermal drug delivery. Controlled and novel drug delivery, 1st ed. New Delhi: CBS Publishers and Distributors. 1997; 100-29.
5. Chien Y, Patani G. Transdermal drug delivery devices: system design and composition. Encyclopedia of Pharmaceutical Technology. 1999; 18: 309-337.
6. Goyal A, Kumar S, Nagpal M, Singh I, Arora S. Potential of Novel Drug Delivery Systems for Herbal Drugs. Indian Journal of pharmaceutical Research and Education. 2011; 45(3): 225-235.
7. Bhairam M, Roy A, Bahadur S, Banafar A, Patel M, Turkane D. Transdermal Drug Delivery System with Formulation and Evaluation Aspects: Overview. Research Journal of Pharmacy and Technology. 2012; 5(9): 1168-1176.
8. Nagdev S, Omprakash A, Mohammed R. Transdermal Drug Delivery System: An Overview. Research Journal of Pharmacy and Technology. 2022; 15(3):1371-7 https://doi: 10.52711/0974-360X.2022.00229
9. Prausnitz M, Langer R. Transdermal drug delivery. Nature biotechnology. 2008; 26(11):1261-8. https://doi.org/10.1038/nbt.1504
10. Patel N, Patel C, Vachhani S, Prajapati S, Patel C. Recent Advances in Transdermal Drug Delivery System. Research J. Pharma. Dosage Forms and Techology. 2010; 2(2):113-119
11. Klose K, Zhou J, Morgan T, Finnin B, Reed B. Transdermal delivery of antiemetics. Google Patents; 2005.
12. Boccia R, Grunberg S, Franco G, Rubenstein E, Voisin D. Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial. Supportive Care in Cancer. 2013; 21(5):1453-60. https://doi: 10.1007/s00520-012-1691-5
13. Zarana M, Darshil B, Dilip A. Development and validation of stability indicating HPLC method for estimation of Ramosetron Hcl. World Journal of Pharmaceutical Resarch. 2014; 3:4527–35.
14. Mujoo S, Ali Z, Jehangir M, Iqbal A, Qayoom N, Lone A. A comparative evaluation of Ramosetron with ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing urological procedures. Anesthia Essays Resarch. 2017; 11(1):78-83. https://doi:10.4103/0259-1162.200244
15. Shailesh T, Patel G, Patel C. Formulation and Evaluation of Transdermal Patch of Repaglinide.ISRNPharmaceutics.2011;34(6):456-461. https://doi:10.5402/2011/651909
16. Stanekzai A, Sudhakar C, Zhakfar A.,Singh K. Recent Approaches in Transdermal Drug Delivery System. Research Journal of Pharmacy and Technology. 2019; 12(9):4550-4558. https://10.5958/0974-360X.2019.00783.2
17. Suryadevara P. Formulation and evaluation of antiemetic patch comprising ondansetron hydrochloride [M.S. thesis], KLE University, Belgaum, India, 2010.
18. Nagadev C, Srinivasa Rao M, Venkatesh P, Hepcykalarani D, Prema R. A Review on Transdermal Drug Delivery Systems. Asian Journal of Research in Pharmaceutical Sciences. 2020; 10(2):109-114. https://10.5958/2231-5659.2020.00021.1
19. Reddy R, Muttalik S, Reddy S. Once daily sustained release matrix tablets of nicorandil: formulation and in-vitro evaluation. AAPS Pharm Sci Tech.2003; 4(4): 480-488. https://10.1208/pt040461
20. Kusum D, Saisivam S, Maria G, Depti P. Design and Evaluation of Matrix diffusion Controlled Transdermal patches of Verapamil Hydrochloride. Drug Delvelopment and Industrial Pharmacy.2003; 29: 495-503. https://10.1081/ddc-120018638
21. Biswajit M, Sushmita M, Gupta R. Comparison between povidone-ethyl cellulose and povidone Eudragit transdermal Dexamethasone matrix patches based on in vitro skin permeation. European Journal of Pharmaceutics and Biopharmaceutics. 2005; 59: 475-483. https://10.1016/j.ejpb.2004.09.009
22. Ismail H, Narayanaswamy V, Injamamul H, Mohibul H. Design and Evaluation of Transdermal Patches Containing Risperidone. Asian Journal of Research in Pharmaceutical Sciences. 2016; 6(4): 208-222. https://10.5958/2231-5659.2016.00030.8
23. Vasavi G, Haritha N, Chandrashekar B. Formulation Development and In vitro Evaluation of Transdermal Patches of Tramadol HCl. Asian Journal of Research in Pharmaceutical Sciences. 2018; 8(3):123-129. https:// 10.5958/2231-5659.2018.00021.8
24. Mazzo D, Obetz C, Shuster J, Brittain H. Analytical profiles of drug substances and excipients. Academic Press Inc., San Diego, CA. 1994; 23: 53.
25. Friend D. In vitro skin permeation techniques. Journal of Controlled Release. 1992; 18(3):235-48. https://doi.org/10.1016/0168-3659(92)90169-R
26. Das A, Ghosh S, Das S, Dey B, Ghosh T. Formulation and In Vitro Evaluation of Transdermal Patches of Metformin Hydrochloride Using Hydrophilic and Hydrophobic Polymer Complex. Research Journal of Pharmacy and Technology. 2011; 4(4): 561-565.
27. Katta M, Shilpa T. Development of Medicated Topical Patches in Transdermal drug delivery system. Research Journal of Pharmacy and Technology. 2018; 11(1): 397-404. https://10.5958/0974-360X.2018.00073.2